SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-23-013687
Filing Date
2023-05-11
Accepted
2023-05-10 18:12:16
Documents
57
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q pirs20230331_10q.htm   iXBRL 10-Q 983413
2 EXHIBIT 31.1 ex_468622.htm EX-31.1 8552
3 EXHIBIT 31.2 ex_468623.htm EX-31.2 9277
4 EXHIBIT 32.1 ex_468624.htm EX-32.1 4142
5 EXHIBIT 32.2 ex_468625.htm EX-32.2 4123
  Complete submission text file 0001437749-23-013687.txt   5133388

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA pirs-20230331.xsd EX-101.SCH 49486
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pirs-20230331_cal.xml EX-101.CAL 35167
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pirs-20230331_def.xml EX-101.DEF 312403
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE pirs-20230331_lab.xml EX-101.LAB 289114
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pirs-20230331_pre.xml EX-101.PRE 332835
51 EXTRACTED XBRL INSTANCE DOCUMENT pirs20230331_10q_htm.xml XML 763098
Mailing Address 225 FRANKLIN STREET 26TH FLOOR BOSTON MA 02110
Business Address 225 FRANKLIN STREET 26TH FLOOR BOSTON MA 02110 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37471 | Film No.: 23908086
SIC: 2834 Pharmaceutical Preparations